Keyword: Biogen Idec Elan Tysabri
News
19.06.2013
- U.S.-based Royalty Pharma has dropped a hostile bid worth up to $8 billion for Elan, leaving the Irish drugmaker free to seek other suitors having put itself up for sale last week...
News
26.01.2011
- Late last year, a handful of executives from Irish drugmaker Elan Corp flew by private jet from San Francisco to New York to notify the board they planned to lay off 130 workers...
